Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析

◆英語タイトル:Amryt Pharma Plc (AMYT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH417512FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amryt Pharma Plc (AMYT) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amryt Pharma Plc (Amryt Pharma) is a biopharmaceutical company which develops and commercializes novel treatments for patients with rare and orphan diseases. It has two marketed products include lomitapide for the treatment of adult HoFH and Metreleptin for the treatment of leptin deficiency. The company is also developing a portfolio of pipeline candidates, AP101 and AP103 targeting multiple orphan diseases such as epidermolysis bullosa. The company offers its products in the US, European Middle East and Africa (EMEA). Amryt Pharma is headquartered in London, the UK.

Amryt Pharma Plc Key Recent Developments

Nov 05,2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07,2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06,2020: Amryt announces Q2 2020 results
Aug 06,2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11,2020: Amryt Pharma : Q1 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amryt Pharma Plc – Key Facts
Amryt Pharma Plc – Key Employees
Amryt Pharma Plc – Key Employee Biographies
Amryt Pharma Plc – Major Products and Services
Amryt Pharma Plc – History
Amryt Pharma Plc – Company Statement
Amryt Pharma Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amryt Pharma Plc – Business Description
Product Category: Lojuxta
Performance
Product Category: Lomitapide
Overview
Product Category: Metreleptin
Overview
Performance
Product Category: Others
Overview
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Amryt Pharma Plc – Corporate Strategy
Amryt Pharma Plc – SWOT Analysis
SWOT Analysis – Overview
Amryt Pharma Plc – Strengths
Amryt Pharma Plc – Weaknesses
Amryt Pharma Plc – Opportunities
Amryt Pharma Plc – Threats
Amryt Pharma Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Oil & Gas Financial Deals and Alliances
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 05, 2020: Amryt reports record Q3 2020 results – raising FY 2020 revenue guidance
Aug 07, 2020: Amryt to present at Virtual Canaccord Genuity 40th Annual Growth Conference
Aug 06, 2020: Amryt announces Q2 2020 results
Aug 06, 2020: Amryt announces Q2 2020 results and issues positive revenue guidance for FY 2020
May 11, 2020: Amryt Pharma : Q1 2020 results
May 11, 2020: Amryt Pharma : FY 2019 results
Mar 23, 2020: AMRYT PHARMA: Strong cash balances coupled with revenue progression
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amryt Pharma Plc, Key Facts
Amryt Pharma Plc, Key Employees
Amryt Pharma Plc, Key Employee Biographies
Amryt Pharma Plc, Major Products and Services
Amryt Pharma Plc, History
Amryt Pharma Plc, Other Locations
Amryt Pharma Plc, Subsidiaries
Amryt Pharma Plc, Key Competitors
Amryt Pharma Plc, Ratios based on current share price
Amryt Pharma Plc, Annual Ratios
Amryt Pharma Plc, Annual Ratios (Cont...1)
Amryt Pharma Plc, Interim Ratios
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amryt Pharma Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amryt Pharma Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amryt Pharma Plc (AMYT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Panhandle Oil and Gas Inc (PHX):石油・ガス:M&Aディール及び事業提携情報
    Summary Panhandle Oil and Gas Inc (Panhandle) sells oil, natural gas liquid (NGL) and natural gas produced from non-operated assets through working interests, royalty interests and both in producing oil and natural gas wells and those in the process of being drilled or completed. The company operate …
  • Nippon Suisan Kaisha, Ltd.
    Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Suisan Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aptiv Plc. (APTV):企業の財務・戦略的SWOT分析
    Aptiv Plc. (APTV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NorgesGruppen ASA:企業の戦略的SWOT分析
    NorgesGruppen ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Shangri-La Asia Ltd:戦略・SWOT・企業財務分析
    Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report Summary Shangri-La Asia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Electromagnetic Geoservices ASA (EMGS):企業の財務・戦略的SWOT分析
    Summary Electromagnetic Geoservices ASA (EMGS) is an oil and gas service provider that explores workflow working with seismic, petrophysical and geologic data. The company gathers controlled source electromagnetic data and conduct modeling, integration, interpretation. Its technology finds applicati …
  • Obton AS:電力:M&Aディール及び事業提携情報
    Summary Obton A/S (Obton) is an investment company that offers management of assets within renewable energy. The company's investment process include screening process which inludes verification of prerequisites such as financial terms, amount of irradiation, power purchase agreement and feed-in tar …
  • Whitehead Institute for Biomedical Research-製薬・医療分野:企業M&A・提携分析
    Summary Whitehead Institute for Biomedical Research (Whitehead Institute), a subsidiary of Massachusetts Institute of Technology is a non-profit research and educational institute that offers technologies to improve human health. The institute undertakes the development of therapies for diseases tha …
  • Alsalam Aerospace Industries:企業の戦略・SWOT・財務情報
    Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report Summary Alsalam Aerospace Industries - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Eesti Energia AS:企業の戦略・SWOT・財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Exact Sciences Corp (EXAS):製品パイプライン分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Repower AG:電力:M&Aディール及び事業提携情報
    Summary Repower AG (Repower), formerly Ratia Energie AG is an energy company that produces, transmits and distributes electricity. The company's services include trading, market access, and sales support services. It generates electric energy from hydropower, wind power plants, and combined-cycle ga …
  • Murree Brewery Co. Ltd.:企業の戦略・SWOT・財務情報
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Abu Dhabi National Energy Co (TAQA):電力:M&Aディール及び事業提携情報
    Summary Abu Dhabi National Energy Company (TAQA), a subsidiary of government-owned Abu Dhabi Water and Electricity Authority, is an energy and water company. It undertakes power generation; exploration, development, production and storage of oil and gas; pipelines and gas storage; and water desalina …
  • SolarWinds North America Inc:企業の戦略的SWOT分析
    SolarWinds North America Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Ocean Power Technologies Inc (OPTT):企業の財務・戦略的SWOT分析
    Ocean Power Technologies Inc (OPTT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • moksha8 Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Moksha8 Pharmaceuticals Inc (moksha8) is a drug company that offers therapeutic products. The company manufactures and commercializes products for the treatment of critical diseases. It provides vilazodone HCI for depressive disorder. moksha8’s other products include vilazodone HCL, mirtazap …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務分析
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Axpo Holding AG-エネルギー分野:企業M&A・提携分析
    Summary Axpo Holding AG (Axpo) is an electricity utility that produces, trades and sells electricity. It is wholly owned by the cantons of Northeastern Switzerland. The company covers the entire value chain from power generation and marketing of a wide range of products to power distribution. It gen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆